Clarify HER2 status right down to the details

The results of the HERmark Assay are given in a simple report that provides a quantitative measurement of the patient's HER2 total protein and HER2 homodimer levels.

The HERmark report clearly states whether a patient is HER2 Negative, Positive or Equivocal and the results are available in approximately seven days after the sample is received.

The report also illustrates where an individual patient's results fit within the continuum of positive and negative HER2 expression.

1HERmark® Assay results were compared to reference methods in 1,090 breast cancer tissue specimens from the Hershey Medical Center/Medical University of Vienna cohort, The Mayo Clinic cohort, and the FinHer Adjuvant Breast Cancer Study to determine the HERmark® Patient Status.